Paul Tudor Jones Bausch Health Companies Inc. Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $44,090 - $55,568	-6,752 Reduced 39.31%	10,423 $83,000
Q3 2023 Nov 15, 2023	BUY	$7.69 - $9.71 $132,075 - $166,769	17,175 New	17,175 $141,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $156,466 - $314,641	34,163 New	34,163 $235,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $251,013 - $322,947	-11,621 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $76,383 - $96,342	-3,321 Reduced 22.23%	11,621 $321,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $374,147 - $449,156	14,942 New	14,942 $416,000
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $198,017 - $236,061	-7,219 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $154,270 - $248,189	7,219 New	7,219 $229,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.